| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/29/2004 | CA2493341A1 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 01/29/2004 | CA2493230A1 5-substituted isoquinoline derivative |
| 01/29/2004 | CA2492941A1 Remedy |
| 01/29/2004 | CA2492922A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | CA2492847A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/29/2004 | CA2492665A1 Azaindole kinase inhibitors |
| 01/29/2004 | CA2492331A1 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 01/29/2004 | CA2492110A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 01/29/2004 | CA2466288A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/28/2004 | EP1384998A1 Eyestrain model, method of constructing the same, evaluation method with the use of the model and drugs screened by using the evaluation method |
| 01/28/2004 | EP1384478A1 Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose |
| 01/28/2004 | EP1384477A1 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases |
| 01/28/2004 | EP1383892A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/28/2004 | EP1383798A2 Transporters and ion channels |
| 01/28/2004 | EP1383789A2 Proteins associated with cell growth, differentiation, and death |
| 01/28/2004 | EP1383787A2 Sapogenin derivatives, their synthesis and use |
| 01/28/2004 | EP1383786A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| 01/28/2004 | EP1383768A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 01/28/2004 | EP1383765A1 Chemical compounds |
| 01/28/2004 | EP1383762A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 01/28/2004 | EP1383750A2 Urea derivatives as integrin alpha 4 antagonists |
| 01/28/2004 | EP1383747A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 01/28/2004 | EP1383746A2 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 01/28/2004 | EP1383730A2 Anticholinergic compounds and methods of use |
| 01/28/2004 | EP1383530A2 Laminin 5, 13 and 14 and uses thereof |
| 01/28/2004 | EP1383529A2 Methods of treating disorders of the eye and surrounding tissue with thymosin 4 (t 4), analogues, isoforms and other derivatives |
| 01/28/2004 | EP1383522A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 01/28/2004 | EP1383521A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue |
| 01/28/2004 | EP1383520A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa |
| 01/28/2004 | EP1383504A1 Sustained release drug delivery system containing codrugs |
| 01/28/2004 | EP1383487A1 Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| 01/28/2004 | EP1383399A1 Nutritional supplement to treat macular degeneration |
| 01/28/2004 | EP1383377A1 Compositions including vitamin-based surfactants and methods for using same |
| 01/28/2004 | EP1183237B1 Novel antioxidants, preparation methods and uses |
| 01/28/2004 | CN1471534A 桥(连)哌嗪衍生物 Bridge (even) piperazine derivatives |
| 01/28/2004 | CN1471527A 喹唑啉衍生物 Quinazoline derivatives |
| 01/28/2004 | CN1471512A Gem-substituted ± ¢ ²3 integrin antagonists |
| 01/28/2004 | CN1470248A Oral liquor for preventing and treating presbyopia and its preparation method |
| 01/28/2004 | CN1470240A Controllable release system of glucocorticoid and its preparation and use |
| 01/28/2004 | CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them |
| 01/28/2004 | CN1135975C Vitamin E and esters therof for use in the topical treatment of mucosal pathologies |
| 01/27/2004 | US6683103 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 01/27/2004 | US6683101 Such as 6-(3-(trans-4-phenylcyclohexylamino)propyl)-3h-benzoxazol-2-one; cerebral vascular disorders |
| 01/27/2004 | US6683096 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 01/27/2004 | US6683093 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 01/27/2004 | US6683088 Sulfonamido ether substituted imidazoquinolines |
| 01/27/2004 | US6683078 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/27/2004 | US6683056 Synergistic mixture with antilipemic agent |
| 01/27/2004 | US6683051 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
| 01/22/2004 | WO2004007696A2 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 01/22/2004 | WO2004007517A1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 01/22/2004 | WO2004007481A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
| 01/22/2004 | WO2004007472A1 Ccr4 antagonist and medicinal use thereof |
| 01/22/2004 | WO2004007468A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/22/2004 | WO2004007464A1 Imidazole derivative |
| 01/22/2004 | WO2004007458A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 01/22/2004 | WO2004007457A2 Substituted benzylamine derivatives and methods of use |
| 01/22/2004 | WO2004007437A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 01/22/2004 | WO2004006889A1 Bioerodible film for ophthalmic drug delivery |
| 01/22/2004 | WO2004006853A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 01/22/2004 | WO2004006850A2 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| 01/22/2004 | WO2004006847A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 01/22/2004 | WO2004006662A1 DISEASE MODEL ANIMAL CARRYING FOREIGN PPARα GENE TRANSFERRED THEREINTO AND USE THEREOF |
| 01/22/2004 | WO2003064383A3 Phosphorus-containing compounds & uses thereof |
| 01/22/2004 | WO2003024390A3 Hydroxyeicosenoic acid analogs |
| 01/22/2004 | WO2002069886A3 Modified proteins, designer toxins, and methods of making thereof |
| 01/22/2004 | US20040014973 Pyridin-4-YL or pyrimidin-4-YL substituted pyrazines |
| 01/22/2004 | US20040014956 For increasing nuclease resistance of antisense sequences |
| 01/22/2004 | US20040014816 Novel aliphatic compounds, process for their preparation and their usage |
| 01/22/2004 | US20040014812 Promote production and secretion of mucin in ophthalmic tissues. Therapeutic agents for keratoconjunctival diseases in the present invention comprise farnesylacetic acid or a salt thereof as an active ingredient. |
| 01/22/2004 | US20040014809 Novel n-( 2-phenyl-3-aminopropyl)naphtamides |
| 01/22/2004 | US20040014793 Stability in blood |
| 01/22/2004 | US20040014783 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 01/22/2004 | US20040014777 Vision disorders |
| 01/22/2004 | US20040014776 Anticancer agents; cyclin-dependent kinase inhibitor |
| 01/22/2004 | US20040014763 beta-sheet mimetics and composition and methods relating thereto |
| 01/22/2004 | US20040014755 Rho-kinase inhibitors |
| 01/22/2004 | US20040014754 Urea substituted imidazoquinolines |
| 01/22/2004 | US20040014746 Antimicrobial thiadiazinone derivatives and their application for treatment of bacterial infections |
| 01/22/2004 | US20040014721 Method for using tethered bis(polyhydroxyphenyls) and O-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 01/22/2004 | US20040014685 Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 01/22/2004 | US20040014132 Comprises immunoglobulins which binds and neutralizes chemoattractants (eotaxin) for modulating inflammatory response; antiinflammtory agents; antiallergens |
| 01/22/2004 | US20040014037 Release factors (RF-1) polypeptides and DNA (RNA) encoding RF-1 polypetides and methods for producing such polypeptides by recombinant techniques; utilizing RF-1 polypeptides to screen for antibiotics |
| 01/22/2004 | US20040013680 Neurotoxic oligomers |
| 01/22/2004 | CA2493373A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 01/22/2004 | CA2492561A1 Treatment and prophylaxis with 4-1bb-binding agents |
| 01/22/2004 | CA2492273A1 3, 10, and 12a substituted tetracycline compounds |
| 01/22/2004 | CA2492164A1 Substituted benzylamine derivatives and methods of use |
| 01/22/2004 | CA2492100A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 01/22/2004 | CA2492045A1 Substituted amine derivatives and methods of use |
| 01/22/2004 | CA2490818A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/22/2004 | CA2489203A1 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 01/21/2004 | EP1382605A2 8-azabicyclo(3.2.1)oct-2-ene derivatives and their use as nAChR ligands |
| 01/21/2004 | EP1381686A2 Inactivation of genes of the mep pathway |
| 01/21/2004 | EP1381626A2 Human transporters and ion channels |
| 01/21/2004 | EP1381620A2 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 01/21/2004 | EP1381607A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepine-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 01/21/2004 | EP1381606A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 01/21/2004 | EP1381602A1 Heterocyclyldicarbamides as caspase inhibitors |
| 01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |